Delivery Order SPE2DB22D1017-SPE2DB24FF3AU
Award Date 2/20/24
Potential Completion Date 2/21/24
Potential Value $1.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,029,396 units of Ondansetron HCl 4 mg tablets in 500-count bottles. The $64,926.98 contract has a performance period ending on March 21, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,691,607 units of the pharmaceutical Ondansetron HCL 8 mg tablets. The contract has a potential value of $1,308.17 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite...
- The U.S. government awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,563,358,978 units of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $12,144.43 and an ultimate completion date of January 22, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supply chain services. AmerisourceBergen holds a larger...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,649,459 units of Ondansetron HCL 8 mg tablets. The $1,839.70 order has a completion date of February 14, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,681,916 units of the pharmaceutical product Ondansetron HCL 8 mg Tablet 30s. The contract has a potential value of $2,228.01 and a completion date of February 16, 2024. This award is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,728,753 units of Ondansetron ODT 8 mg tablets. The $3,297.64 contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) valued up...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania. The $13,813.36 contract is for the supply of 4,564,134,450 units of the pharmaceutical product ondansetron HCL 4 mg tablet. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,125,413 units of the prescription drug Ondansetron ODT 8mg Tablet. The contract, valued at $1,189.99, has an ultimate completion date of April 1, 2024. As the prime contractor, Amerisourcebergen Drug Corp will deliver these pharmaceutical products from its Corporate Office in Conshohocken, Pennsylvania to support...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract valued at $3,275.66 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,980,486 units of the pharmaceutical product Ondansetron HCl 8 mg tablets. This delivery order was placed under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of up to $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,678,777 units of Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $5,996.20 and an ultimate completion date of September 5, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...